2023 Best of Lung: Targeted Therapies in Lung Cancer

Поділитися
Вставка
  • Опубліковано 3 січ 2025
  • In this session from the Total Health 2023 Best of Lung conference, Dr Jaime Schneider from Massachusetts General Hospital Cancer Center discusses the use of targeted treatments in lung cancer.

КОМЕНТАРІ • 12

  • @prajapatiparth3685
    @prajapatiparth3685 6 місяців тому

    In ros 1 nsclc which medicine is best crizotinib or ceritinib?

  • @ashutoshvyas885
    @ashutoshvyas885 11 місяців тому +3

    Squamous cell carcinoma alk positive cancer me best ky h

    • @rajib17cmc
      @rajib17cmc 10 місяців тому

      ALK positive is very rare in squamous cell carcinoma. But may happen in females and non smokers.
      Best treatment is a group of drug called ALK TKI. Lorlatinib, Alectinib are the best among them.

  • @krhyou
    @krhyou 4 місяці тому +1

    Informative. But you speak very fast. Closed captioning can’t keep up. I’m trying to learn from this seminar but can’t decipher all of what you are saying. I will have to watch this video at leastc2 times. Thank you for your information about Tagrisso and NSCLC.

    • @Jeweldee
      @Jeweldee 2 місяці тому

      If you go to settings on top right you can control speed.

  • @susancrounse7030
    @susancrounse7030 9 місяців тому

    So with squamous nsclc my best bet after radiation,chemo,and immuni therapy is I’m still looking at a year at best

    • @gygi3490
      @gygi3490 9 місяців тому

      So live that year to the best!

    • @gygi3490
      @gygi3490 9 місяців тому +1

      So live that year to the best

    • @Deepakchandrasekaran007
      @Deepakchandrasekaran007 Місяць тому

      You ll live long much longer

  • @kathb1683
    @kathb1683 10 місяців тому +1

    TKI side effects?!

    • @Deepakchandrasekaran007
      @Deepakchandrasekaran007 Місяць тому +1

      Very good question TKI they'll definitely impact other areas of the body it's a diversified kinase.